|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,470.00 KRW | +4.59% |
|
+12.44% | -19.79% |
| 12-09 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 25-06-12 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | 1.79x | - | 17.49x | 91.24M | |
| -.--% | -.--% | -228.42x | 23.59x | 15.51x | -279.69x | -199.65x | 45.89B | |
| 0.9% | 0.92% | 23.36x | 2.92x | 2.12x | 12.14x | 14.69x | 26.06B | |
| 4.79% | 4.88% | 18.27x | 1.27x | 1.39x | 7.91x | 14.52x | 7.82B | |
| 0.95% | 1.02% | 52.52x | 11.44x | 9.73x | 33.52x | 41.58x | 3.42B | |
| -.--% | -.--% | -56.14x | - | - | - | - | 2.14B | |
| 1.36% | 1.76% | 37.75x | 2.06x | 1.93x | 14.77x | 23.32x | 2.13B | |
| 4.92% | 6.54% | 13.54x | 1.96x | 1.32x | 5.24x | 8.36x | 2.01B | |
| 0.76% | 1.31% | 32.48x | 1.97x | 1.26x | 9.98x | 14.55x | 1.91B | |
| 0.12% | 0.12% | 83.64x | 15.03x | 17.43x | 43.02x | 58.66x | 1.5B | |
| 0.53% | 0.62% | 46.38x | 7x | 6.04x | 23.57x | 33.65x | 1.24B | |
| 3.54% | 3.54% | 35.43x | 1.45x | 0.84x | 6.96x | 23.66x | 1.22B | |
| 1.77% | 2.05% | 47.36x | 15.56x | - | - | - | 1.04B | |
| 0.33% | 0.4% | 29.5x | 2.22x | - | - | - | 912M | |
| 3.5% | 3.92% | 17.79x | 1.03x | - | - | - | 843M | |
| Average | 1.68% | 1.93% | 10.96x | 6.73x | 5.40x | -12.26x | 4.62x | 6.55B | |
| Weighted average by Cap. | 0.9% | 0.98% | -93.58x | 13.25x | 9.17x | -130.66x | -88.62x |
- Stock Market
- Stocks
- A340450 Stock
- Sector GC Genome Corporation
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
